GRDN — Guardian Pharmacy Services Share Price
0.000.00%
Last trade - 00:00- $1.53bn
- $1.54bn
- $1.23bn
- 89
- 29
- 87
- 77
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | 28.23 | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 10.73 | ||
| Price to Tang. Book | 26.2 | ||
| Price to Free Cashflow | 36.82 | ||
| Price to Sales | 1.25 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -35.61% | ||
| Return on Equity | -128.8% | ||
| Operating Margin | -5.12% | ||
Financial Summary
| Year End 31st Dec | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $m | 735.96 | 792.07 | 908.91 | 1,046.19 | 1,228.41 | 1,341 | 1,376.29 | 11.96% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | -8.29 | -18.2 | +117.12 | -100 | n/a | n/a | +22.5 | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Guardian Pharmacy Services, Inc. is a pharmacy services company. The Company provides a suite of technology-enabled services designed to help residents of long-term health care facilities (LTCFs) adhere to their appropriate drug regimen, which in turn helps reduce the cost of care and improve clinical outcomes. Through its locally based pharmacies, the Company utilizes a complex, technology-enabled platform to manage the dispensing and administration of prescriptions to residents of LTCFs over the full prescription lifecycle in order to manage medication risk. Its services include GuardianShield, provider services, and others. Its Guardian Compass platform offers insights to enhance efficiencies for its pharmacies, including proprietary real-time operational dashboards and metrics. Its suite of GuardianShield products offers customer and clinical services that benefit both the residents it serves and their caregivers. It serves assisted living and memory care, hospice care and others.
Directors
- Last Annual
- December 31st, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- November 16th, 2021
- Public Since
- September 26th, 2024
- No. of Shareholders
- 335
- No. of Employees
- 3,400
- Sector
- Food & Drug Retailing
- Industry
- Consumer Defensives
- Exchange
- New York Stock Exchange
- Shares in Issue
- 63,287,158
- Address
- 300 Galleria Parkway SE, Suite 800, ATLANTA, 30339
- Web
- https://guardianpharmacy.com/
- Phone
- +1 4048100089
- Auditors
- Ernst & Young LLP
Upcoming Events for GRDN
Similar to GRDN
Albertsons Companies
New York Stock Exchange
BBB Foods
New York Stock Exchange
Fomento Economico Mexicano SAB de CV
New York Stock Exchange
Kroger Co
New York Stock Exchange
Performance Food Co
New York Stock Exchange
FAQ
What is the Guardian Pharmacy Services share price?
As of Today at 20:58 UTC, shares in Guardian Pharmacy Services are trading at $24.20. This share price information is delayed by 15 minutes.
How has the Guardian Pharmacy Services share price performed this year?
Shares in Guardian Pharmacy Services last closed at $24.20 and the price had moved by over the past 365 days. In terms of relative price strength the Guardian Pharmacy Services share price has matched the S&P500 Index by over the past year.
What are the analyst and broker recommendations for Guardian Pharmacy Services?
The overall consensus recommendation for Guardian Pharmacy Services is Buy. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreWhat is the Guardian Pharmacy Services dividend yield?
Guardian Pharmacy Services does not currently pay a dividend.
Does Guardian Pharmacy Services pay a dividend?
Guardian Pharmacy Services does not currently pay a dividend.
When does Guardian Pharmacy Services next pay dividends?
Guardian Pharmacy Services does not currently pay a dividend.
How do I buy Guardian Pharmacy Services shares?
To buy shares in Guardian Pharmacy Services you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Guardian Pharmacy Services?
As of the previous close price of $24.20, shares in Guardian Pharmacy Services had a market capitalisation of $1.53bn.
Where are Guardian Pharmacy Services shares listed?
Here are the trading details for Guardian Pharmacy Services:
- Country of listing: United States
- Exchange: NYQ
- Ticker Symbol: GRDN
What kind of share is Guardian Pharmacy Services?
Based on an overall assessment of its quality, value and momentum Guardian Pharmacy Services is currently classified as a High Flyer. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Guardian Pharmacy Services share price forecast for 2025?
The analyst consensus target price for shares in Guardian Pharmacy Services is $25.00. That is 3.31% above the last closing price of $24.20.
Analysts covering Guardian Pharmacy Services currently have a consensus Earnings Per Share (EPS) forecast of $0.80 for the next financial year.
Find out moreWhat is the trend in the Guardian Pharmacy Services share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Guardian Pharmacy Services. Over the past six months, its share price has outperformed the S&P500 Index by +48.47%.
As of the last closing price of $24.20, shares in Guardian Pharmacy Services were trading +16.61% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Guardian Pharmacy Services PE Ratio?
The Guardian Pharmacy Services PE ratio based on its reported earnings over the past 12 months is 28.23. The shares last closed at $24.20.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Guardian Pharmacy Services?
We do not have data on Guardian Pharmacy Services' directors